Moderna Inc on Tuesday applied for European authorization of its Covid-19 vaccine in children aged 6-11 years, weeks after it delayed a similar filing with US regulators.
Moderna Inc on Tuesday applied for European authorisation of its Covid-19 vaccine in children aged 6-11 years, weeks after it delayed a similar filing with US regulators.
Moderna said in late October the US drugs regulator needed more time to complete its review for use in the 12-17 age group as it studies the risk of a type of heart inflammation called myocarditis after vaccination.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer says its antiviral pill slashes risk of severe Covid-19 by 89%Pfizer Inc's experimental antiviral pill to treat COVID-19 cut by 89% the chances of hospitalization or death for adults at risk of severe disease, the company said on Friday.
Read more »
Pfizer’s Covid-19 pill boosts shares from casinos to airlinesDrug could reduce hospitalisation and deaths in high-risk patients by 89%, company says
Read more »
Re-analysis of ivermectin: When shaky science was removed, its Covid-19 benefits 'decreased' | Health24Researchers re-evaluated studies on ivermectin for Covid-19 and found that when potential bias and medical fraud were removed, the drug had no significant benefit. | zakiyahebrahim Health24com
Read more »
Oxford scientists find gene that doubles risk of dying from Covid-19The findings help explain why higher rates of hospitalisation and death may have been seen in India
Read more »